Latest from Incanthera

News

December 8th, 2020 Incanthera says development of skin cancer asset Sol has gone 'way beyond any expectations'
December 4th, 2020 Notice of Interim Results - Investor Presentation
October 7th, 2020 Incanthera believe new skin cancer prevention cream reveals 'all positives and no negatives'
September 29th, 2020 Completion of Subscription Agreements
September 29th, 2020 Incanthera completes £350,000 fundraising, with ImmuPharma increasing stake
September 28th, 2020 Incanthera receives positive data skin sensitisation study of skin cancer technology Sol